来自年轻血的外体刺激骨质分化,并通过miR-142-5p预防骨质疏松症
Zhikun Li1,2, Qifeng Yu1,2, Xiang Cui2
1Department of Orthopedic, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Bioactive materials
|April 10, 2025
概括
血外生体对治疗骨质疏松症有前途,特别是来自年轻捐赠者的外生体. 这些外体促进骨形成并减少骨分解,为骨质疏松症患者提供了潜在的新疗法.
科学领域:
- 生物医学科学 生物医学科学
- 再生医学是一种再生医学.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨质疏松症 (OP) 是老年人,特别是绝经后妇女的一种常见的代谢性骨疾病.
- 传统的抗骨质疏松药物由于副作用而存在局限性,需要替代疗法.
研究的目的:
- 为了研究血衍生异体的治疗潜力,用于骨质疏松症.
- 为了阐明外体介导的抗骨质疏松作用的潜在机制.
主要方法:
- 介质干细胞 (MSC) 用来自年轻和老年健康人体血的外体进行治疗.
- 在体外测试中评估了MSC的扩散,迁移,性酸酶 (ALP) 活性和矿化.
- 在体内研究中使用了卵巢切除 (OVX) 诱导的骨质疏松性大鼠模型.
- miRNA测序确定了关键的调节分子,包括miR-142-5p.
主要成果:
- 血外体在体外增强了MSC的扩散,迁移,ALP活动和矿化.
- 外体细胞积聚在骨组织中,并在OVX大鼠模型中证明了体内治疗效果.
- 来自年轻捐赠者的外基因组与老年捐赠者相比,显示出更强的抗骨质疏松作用.
- 在年轻的外体中,miR-142-5p显著高于年轻外体,并促进了骨质生成分化.
结论:
- 血外体,特别是来自年轻的捐赠者,具有显著的抗骨质疏松症潜力.
- miR-142-5p在调解年轻血外体的亲骨质效应方面发挥着至关重要的作用.
- 血外体代表了骨质疏松症治疗的有前途的无细胞治疗策略.
相关概念视频
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:17Hormones and Bone Tissue
2.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K